James Webb
Podiatrist · Bartlesville, OKNPI 1679561385
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (49.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Pylant Medical at 37.4% of the total. Reporting peaked in 2019 at $1,647 and has fallen 77.7% since, to $367 in 2025.
Across 61 payments — averaging $42.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$972
- Stryker$432
- DJO, LLC$224
- Spinefrontier, Inc.$187
- Smith+Nephew$186
- Zyla Life Sciences, Inc.$159
- plus $441 from 9 others
What the payments were for
- Consulting fees$1004%
- Food & beverage$1,21347%
- Education$1,28850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 1 | $972 |
| Stryker | 3 | $432 |
| DJO, LLC | 3 | $224 |
| Spinefrontier, Inc. | 1 | $187 |
| Smith+Nephew | 9 | $186 |
| Zyla Life Sciences, Inc. | 24 | $159 |
| Comsort, Inc | 1 | $100 |
| Rikco International, LLC | 2 | $88 |
| Merck | 7 | $67 |
| Amgen(2 entities) | 3 | $42 |
| Organogenesis Inc. | 2 | $39 |
| Nevro Corp. | 2 | $35 |
| Johnson & Johnson | 1 | $34 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| KCI USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIO4$260
- InSpan$187
- SIJFuse$187
- FacetFuse$187
- NanoFuse$187
- AUGMENT INJECTABLE$172
- SONICANCHOR$140
- ALLOWRAP$120
- DR COMFORT$112
- Santyl$108
- REGRANEX$108
- Oasis$108
- SIVEXTRO$100
How this compares
$2,602 in reported general payments places this provider in the 60th percentile of 54 podiatrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 14 | $4,476 |
| Diclofenac Sodium | 209 | $1,741 |
| Pregabalin | 108 | $1,432 |
| Amitriptyline Hcl | 78 | $752 |
| Duloxetine Hcl | 43 | $485 |
| Ropinirole Hcl | 24 | $429 |
| Gabapentin | 34 | $426 |
| Mupirocin | 61 | $408 |
| Terbinafine Hcl | 20 | $407 |
| Celecoxib | 14 | $390 |
| Ketoconazole | 12 | $376 |
| Methylprednisolone | 46 | $310 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $282 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $156 |
| Azithromycin | 30 | $148 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $186 | $4,47614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 54 podiatrist providers in Oklahoma.
Other podiatrist in Bartlesville
- David CavallaroOklahoma City$22K
- Ahmed BukshEdmond$17K
- Aerial AveryAda$13K
- Patricia BoehleOklahoma City$10K
- Kevin DuxMuskogee$8K
- Barinder BassiTahlequah$7K
- Greg RohdeNorman$7K
- Thomas WicksChickasha$6K
- Tera SantistevanSapulpa$5K
- James StoughEnid$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.